Extensive research has demonstrated a strong connection between microRNA (miRNA) dysregulation and the progression of several diseases, such as cancers and, neurological and cardiovascular diseases.1,2 Understanding the miRNA functional activity can provide deep insights into disease pathophysiology, allowing the development of precise diagnosis and therapies. MiRNAs play an indispensable role in diverse cellular mechanisms (e.g., cell differentiation and apoptosis) by post-transcriptionally regulating gene expression through complementary base pairing with messenger RNA.3 The limited sensitivity of experimental approaches, however, has made the identification of human miRNA targets challenging. Several computational methods for predicting putative miRNA-mRNA interaction have been developed to fill this gap, but with limited predictive capability.4-6 In this study, we present a predictive model for identification of novel miRNA-target mRNA interactions (PRIMITI), using novel common characteristics extracted from high-throughput CLIP binding7,8 and expression data5. Common characteristics include site type, binding stability, site accessibility, site conservation, 3’-supplementary binding, and site interaction.9,10 PRIMITI has been assessed and validated via both cross-validation and an independent blind test showing consistent predictive performance.11 We will compare the predictive capability of PRIMITI with three other state-of-the-art models, TargetScan,4 miRTarget,5 and DIANA-microT-CDS,6 on external validation datasets of HITS-CLIP12 and microarray13 under different criteria, including recall, Pearson’s correlation, and mean repression of top predicted targets. The model will be made available as a freely accessible web server. PRIMITI will be an invaluable resource for analyzing potential miRNA-mRNA interactions and functional significance in molecular mechanisms.